Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer

This study has been completed.
Sponsor:
Collaborator:
Pharmacia and Upjohn
Information provided by (Responsible Party):
Miguel Villalona, Ohio State University Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00201747
First received: September 12, 2005
Last updated: December 18, 2012
Last verified: December 2012